Clinical Trials, Industry, Research and Development, Vaccines
September 15, 2022
Via: Biopharma DiveAn experimental meningococcal vaccine that protects against five strains of the bacteria succeeded in a Phase 3 clinical trial, Pfizer said Thursday, potentially offering an alternative to existing shots that cover fewer variants and require more doses. By the end […]
September 26, 2023
September 21, 2023
September 19, 2023
September 14, 2023
September 7, 2023
September 1, 2023
September 19, 2023
September 5, 2023